14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.25 $5.20 Thursday, 25th Apr 2024 AVXL stock ended at $3.39. This is 0.587% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.62% from a day low at $3.25 to a day high of $3.47.
90 days $3.25 $6.90
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Sep 20, 2023 $7.12 $7.92 $7.07 $7.24 1 461 974
Sep 19, 2023 $7.12 $7.13 $6.81 $7.12 1 098 136
Sep 18, 2023 $7.79 $7.84 $7.07 $7.13 1 487 664
Sep 15, 2023 $8.00 $8.03 $7.55 $7.57 2 689 932
Sep 14, 2023 $7.98 $8.39 $7.57 $7.95 2 750 507
Sep 13, 2023 $7.73 $8.02 $7.64 $7.66 715 076
Sep 12, 2023 $7.75 $7.85 $7.67 $7.75 650 376
Sep 11, 2023 $7.87 $7.89 $7.65 $7.75 553 768
Sep 08, 2023 $7.72 $7.88 $7.64 $7.87 576 758
Sep 07, 2023 $7.75 $7.83 $7.68 $7.71 780 631
Sep 06, 2023 $7.84 $7.89 $7.71 $7.81 617 267
Sep 05, 2023 $7.92 $8.02 $7.80 $7.87 505 506
Sep 01, 2023 $7.92 $8.09 $7.88 $7.94 552 882
Aug 31, 2023 $7.90 $8.02 $7.80 $7.90 674 625
Aug 30, 2023 $7.94 $8.02 $7.84 $7.92 447 596
Aug 29, 2023 $7.91 $7.98 $7.77 $7.95 598 657
Aug 28, 2023 $8.07 $8.15 $7.87 $7.93 404 942
Aug 25, 2023 $7.86 $8.08 $7.77 $8.04 593 377
Aug 24, 2023 $8.03 $8.08 $7.60 $7.75 988 818
Aug 23, 2023 $8.18 $8.22 $8.00 $8.02 383 422
Aug 22, 2023 $8.21 $8.28 $8.01 $8.14 475 359
Aug 21, 2023 $8.16 $8.32 $8.01 $8.17 602 296
Aug 18, 2023 $8.01 $8.33 $7.97 $8.16 448 541
Aug 17, 2023 $8.60 $8.75 $8.10 $8.12 961 642
Aug 16, 2023 $8.88 $8.89 $8.62 $8.62 651 797
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT